Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 8 December 2006. doi:10.1136/jcp.2006.042507
Journal of Clinical Pathology 2007;60:927-930
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experience

Thomas P Thamboo1, Katie J M Jeffery2, Peter J Friend3, Gareth D H Turner4, Ian S D Roberts4

1 Department of Pathology, National University of Singapore, National University Hospital, Singapore
2 Department of Microbiology, John Radcliffe Hospital, Oxford, UK
3 Renal Transplant Unit, Churchill Hospital, Oxford, UK
4 Department of Cellular Pathology, John Radcliffe Hospital, Oxford, UK

Correspondence to:
Ian S D Roberts
Department of Cellular Pathology, John Radcliffe Hospital, Oxford OX3 9DU, UK; ian.roberts{at}orh.nhs.uk

Objective: To review the first year of a monthly urine cytology screening service, introduced to identify renal transplant patients at risk of polyoma virus nephropathy (PVN), at an early, potentially treatable, stage.

Methods and results: Monthly urine samples (n = 392) were received from 97/108 transplant recipients in 2005. Of 56 patients with follow-up >6 months, 20% and 9% had significant (>10 decoy cells/cytospin) and non-significant positive cytology, respectively. The first positive urine samples occurred most commonly in the second and third month post-transplantation and patients with significantly positive samples had higher 3-month and 6-month serum creatinine levels than patients with negative urine cytology (p<0.01). Four patients with positive urine cytology had a subsequent positive plasma BK virus PCR; 3/97 patients had biopsy-proven PVN, all in the third month, 1–6 weeks after first positive urine samples.

Conclusions: Significant PV viruria is common following renal transplantation with onset usually within the first 3 months. Viruria is associated with worse graft function at 3 and 6 months. The time between urine positivity and clinical PVN is short. More frequent early urine screening would be required to achieve clinical benefit.

Abbreviations: PVN, polyoma virus nephropathy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Hilton, R., Tong, C. Y. W. (2008). Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation. J Antimicrob Chemother 62: 855-859 [Abstract] [Full Text]  
  • Weiss, A. S., Gralla, J., Chan, L., Klem, P., Wiseman, A. C. (2008). Aggressive Immunosuppression Minimization Reduces Graft Loss Following Diagnosis of BK Virus-Associated Nephropathy: A Comparison of Two Reduction Strategies. CJASN 3: 1812-1819 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs